Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Filip Casselman
Performed since the mid 1990's, minimally invasive heart valve surgery avoids complete sternotomy, for reduced trauma and pain in the early postoperative period. Compared to the conventional full median sternotomy surgical approach, standardised techniques of minimally invasive heart surgery have shown growing evidence of similar or better results. Explore them here.
Minimally Invasive Heart valve Sugery (MIHVS) is commonly performed through a right mini thoracotomy (1 2,3), a parasternal incision - adjacent to the sternum - or a hemi-sternotomy. Available evidence shows comparable or better results compared to the conventional surgical approach (4, 5, 6, 7) which involves a full median sternotomy. Antegrade ascending aorta cannulation is adopted whenever possible (usually for aortic valve surgery). Another commonly used option is femoral artery cannulation with retrograde arterial perfusion. Although there has been debate over whether retrograde arterial perfusion carries a higher incidence of stroke and other vascular complications (8,13,14) it is frequently used because it is believed that benefits far outweigh risks. Venous cannulation is performed through the right atrial appendage or through the internal jugular and femoral veins for bicaval access. After institution of CardioPulmonary Bypass (CPB) the aortic cross clamp is applied to the ascending aorta, endoluminally in mitral & tricuspid valve surgery, using the endoballoon (Edwards Lifesciences, Irvine, CA, USA) or externally in aortic valve surgery (11). Transesophageal echocardiography plays an important role in MIHVS in assessment and repair of valve pathology, canulae placement and de-airing of the heart following the valve procedure.
Various approaches are adopted, usually as per surgeon’s preference:
The Skin incision is mid-sternum extending from 5 to 7 cms. (Fig -1) Sternotomy is then performed extending from the upper end to the 3rd or 4th inter costal space (ICS) with a J slit to the right half of the sternum (6). Fig-1, Ministernotomy incision: the incision starts 2 cm cephalad of the angle of Louis.
If the sternum is split on both sides at this level it is termed reverse T sternotomy, this may give a better exposure of the aortic root in some patients. With this approach, the internal mammary artery (IMA) is not divided and antegrade arterial and venous cannulation of the right atrial appendage is usually adopted. (Fig- 2)
Additional jugular venous access of the superior vena cava (SVC) or bicaval cannulation with femoral and jugular venous access is performed for better venous drainage, depending on surgeon's preference & practice. (Fig-3)
The aortic cross clamp is applied on the ascending aorta. The aorta is then opened, native valve excised and a new prosthesis is implanted.
This constitutes an alternative approach. The incision is made along the 2nd right or 3rd ICS guided by a preoperative CT scan assessment. The incision extends laterally for 5 to 8 cms from the parasternal border (14). The pericardium is entered and antegrade aortic and femoral venous cannulation is usually adopted. This approach typically increases the working distance to the aortic valve, which may create an additional surgical challenge. Advocates of this technique claim reduced postoperative pain. Therefore, this approach has been deemed by some to be less invasive than a J or T sternotomy but given the increased working distance, its application may be optimised by using sutureless valves.
This approach has currently mostly been abandoned. The incision extends from the lower end of 2nd ICS to the superior end of 5th ICS (16). The right IMA is ligated and 3rd & 4th costal cartilages are excised to enter the thoracic cavity. Retrograde arterial and femoral venous cannulation with centrifugal pump to assist venous drainage has been used in this approach. Surgical exposure is adequate to even perform aortic root procedures but disruption of costal cartilages and IMA ligation may cause increased incidence of chest wall instability and related complications (17).
A 5 to 7 cm incision is made along the infra mammary crease and the thorax is entered through the 4th/5th ICS. Rib spreading is avoided using a soft tissue retractor. (Fig –4)
Fig -4, Minithoractomy- The 5cm incision is held open using a soft tissue retractor. Two other ports for camera and pulmonary venous vent are visible. Carbon dioxide is insufflated into the surgical field through a side arm.Three ports are generally used and surgery is performed with the aid of a video thoracoscope. (13,15,21). Retrograde aortic cannulation and bicaval cannulation through jugular and femoral venous access is performed. (Fig – 5)
Fig -5, Retrograde arterial cannulation with endo balloon inserted through the side arm of the aorterial canula is used with port access. Femoral vein cannulation is seen medial to the arterial cannula.
The aortic cross clamp is placed directly on the ascending aorta using a Chitwood clamp (Scanlan International Inc., St. Paul, MN) (11) or an endoballoon clamp. (9,13). Following cardioplegia instillation and cardiac arrest the left atrium is opened and the valve exposed by means of a left atrial retractor. Mitral valve repair is then guided by high definition two-dimension video image assistance. (Fig –4) Port access is now a standardised approach in specialist centres (4,12,13,17). (Fig-6)Other surgical procedures can also be performed through this approach, these include:
Fig -6, Post operative incision and drainage ports, immediately after port access mitral valve surgery.
Upper or lower Hemi-sternotomy is also performed to access the mitral valve. The consensus is to minimise sternal splitting. Antegrade aortic cannulation may be possible in upper hemi-sternotomy. Venous access is usually through bicaval peripheral venous access. (19)
As described above, is less commonly used - in cases to approach the mitral valve. Access to the mitral valve is trans septal, cutting through the right atrium and the inter atrial septum. Other approaches described above access through the valve directly by cutting through the roof of left atrium.
This procedure is performed using the da Vinci telemanipulation system (Intuitive Surgical, Mountain View, Calif) through multiple ports. Da Vinci system provides a high-resolution, 3-dimensional video image, allowing remote, tremor-free, and scaled control of endoscopic surgical instruments. (23,24).
The surgical steps are similar to Port access surgery and are adopted to gain exposure to the mitral valve. A Right minithoracotomy of 3 to 5 cms is performed through which the 3-dimensional videoscope is inserted (Fig-7). Fig-7, Camera port and working ports are shown in this image.
Other instruments are inserted through additional trocars between second to sixth intercostal spaces in the right thoracic cavity. Mitral valve repair is then performed remotely from the surgical console (fig-8). The Selection of an appropriate ring size is based on the preoperative TEE measurement of the free length of the anterior leaflet (longitudinal view) and by intraoperative endoscopic measurements using custom-made sizers.
Fig-8, Schematic diagram describing the lay out of Operating Room during Roboric Mitral Valve Surgery. Robotic arms are placed to the right of the patient.
A major disadvantage of the robotic system is the cost involved. Other drawbacks of the robotic method are the loss of tactile sensation and the necessity of an additional table-side surgeon. With the development of adjunct technologies however, the technique of computer-enhanced endoscopic cardiac surgery may potentially become more prevalent (21,23).
The advantages of minimally invasive heart valve surgery repair are:
The pitfalls of MIHVS are:
The advent of sutureless aortic valves should make minimally invasive aortic valve replacements easier and quicker through less invasive approaches with reduced risk of stroke. The clinical experience with sutureless valves is increasing worldwide. In contrast to transcatheter aortic valve replacement this approach entails removal of all pathological leaflet and annular aortic valve calcification, thus facilitating the implantation of a larger expandable prosthesis. Sutureless bovine valve are constructed on a self-expandable stent, which can be inserted and released to fit in the aortic annulus after debridement of the aortic annulus (26,27,28). For a closer look at sutureless valves, look here.
1) Minimally invasive cardiac valve surgery improves patient satisfaction while reducing costs of cardiac valve replacement and repair.L. H. Cohn, D. H. Adams, G. S. Couper et al. Annals of Surgery, vol. 226, no. 4, pp. 421–428, 1997.2) First open heart operation (mitral valvuloplasty) under videosurgery through a minithoracotomyA. Carpentier, D. Loulmet, A. Carpentier et al., Comptes Rendus de l’Academie des Sciences III, vol. 319, no. 3, pp. 219–223, 1996.3) The evolution of minimally invasive mitral valve surgery—2 year experience.F. W. Mohr, J. F. Onnasch, V. Falk et al., European Journal of Cardio-Thoracic Surgery, vol. 15, no. 3, pp. 233–239, 1999.4) Minimally invasive mitral valve surgery: a systematic review and meta-analysis.P. Modi, A.Hassan, and W.R.ChitwoodJr., European Journal of Cardio-Thoracic Surgery, vol. 34, no. 5, pp. 943–952, 20085) A minimally invasive approach for aortic valve operations. Cosgrove DM III, Sabik JF. Ann Thorac Surg 1996;62:596–76) Minimally Invasive Versus Standard Approach Aortic Valve Replacement: A Study in 506 PatientsBakir I, Casselman FP, Venermen H, et al Ann Thorac Surg 2006;81:1599-16047) Does ministernotomy improve postoperative outcome in aortic valve operation? A prospective randomized study.Bonacchi M, Prifti E, Giunti G, Frati G, Sani G. Ann Thorac Surg 2002;73:460-4668) Minimally invasive versus open mitral valve surgery: a consensus statement of the international society of minimally invasive coronary surgery (ISMICS) 2010V. Falk, D. C. H. Cheng, J. Martin et al., Innovations, vol. 6, no. 2, pp. 66–76, 2011.9) Minimally invasive valve surgery with antegrade perfusion strategy is not associated with increased neurologic complicationsE. A. Grossi, D. F. Loulmet, C. F. Schwartz et al., The Annals of Thoracic Surgery, vol. 92, no. 4, pp. 1346–1350, 2011.10) Editorial analysis: impact of perfusion strategy on stroke risk for minimally invasive cardiac surgeryD. W. Yaffee, A. C. Galloway, and E. A. Grossi, European Journal Cardio-Thoracic Surgery, vol. 41, no. 6, pp. 1223–1224, 2012 11) Minimally invasive mitral valve repair using transthoracic aortic occlusionW. R. Chitwood Jr., J. R. Elbeery, and J. F. Moran, Annals of Thoracic Surgery, vol. 63, no. 5, pp. 1477–1479, 199712) Avoiding vascular complications during minimally invasive, totally endoscopic intracardiac surgery.Jeanmart H, Casselman FP, Venermen H, et al Ann Thorac Surg 2006;81:1599-160413) Endoscopic mitral valve repair: feasible, reproducible, and durable. Casselman FP, Van Slycke S, Dom H, Vanerman H, et al. J Thorac Cardiovasc Surg2007;133:1066-107014) Impact of minimally invasive valvular heart surgery: a case-control studyE. A. Grossi, A. C. Galloway, G. H. Ribakove et al., Annals of Thoracic Surgery, vol. 71, no. 3, pp. 807–810, 2001.15) From classical sternotomy to truly endoscopic mitral valve surgery: a step-by-step procedure.Casselman FP, Van Slycke S, Wellens F, et al. Heart Lung Circ 2003; 12:172–7.16) Minimally invasive approach for Aortic valve operationsCosgrove DM, Sabik J Annals of Thoracic Surgery, vol. 65, 1535– 1539, 199817) Minimally invasive mitral valve operations.Navia JL, Cosgrove 3rd DM. Ann Thorac Surg 1996;62(November (5)):1542—418) Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients J. Seeburger, M. A. Borger, V. Falk et al., European Journal of Cardio-Thoracic Surgery, vol. 34, no. 4, pp. 764–765, 200819) Hemi-sternotomy approach for aortic and mitral valve surgeryA. M. Gilliov, M. K. Banbury, and D. M. Cosgrove, Journal of Cardiac Surgery, vol. 15, no. 1, pp. 15–20, 2000.20) Video-assisted minimally invasive mitral valve surgery: the ‘micro- mitral’ operationW. R. Chitwood Jr., J. R. Elbeery, W. H. H. Chapman et al., The Journal of Thoracic and Cardiovascular Surgery, vol. 113, no. 2, pp. 413–414, 1997.21) State of the art review: videoscopic minimally invasive mitral valve surgery. Trekking to a totally endoscopic operation,W.R.Chitwood, The Heart Surgery Forum, vol. 1, no. 1, pp. 13–16, 1998.22) Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy.Cohn LH, Trehan H, Collins JJ Jr. Am J Cardiol. 1992; 70: 657–660.23) The evolution and early experience with robot-assisted mitral valve surgeryJ. E. Felger, L. W. Nifong, and W. R. Chitwood Jr., Current Surgery, vol. 58, no. 6, pp. 570–575, 2001.24) Enhanced “ROBOTIC” Cardiac Surgery: Experience in 148 patients, Journal of Thoracic and Cardiovascular Surgery 2001F.W. Mohr, V. Falk, A. Diegeler, et al. Computer –; 121:842-5325) Mitral valve operation via Port Access versus median sternotomyD. D. Glower, K. P. Landolfo, F. Clements et al., European Journal of Cardio-Thoracic Surgery, vol. 14, supplement 1, pp. S143–S147, 1998.26) Sutureless aortic valve replacement with the 3f Enable aortic bioprosthesis.Martens S, Ploss A, Sirat S, Miskovic A, Moritz A, Doss M. Ann Thorac Surg. 2009; 87:1914-7.27) Suture-less Perceval S aortic valve replacement: a multicenter, prospective pilot trial. ShresthaM, FolliguetT, Meuris B,Dibie A, Bara C, Herregods MC, etal. J Heart Valve Dis. 2009; 18:698-702.28) Next Generation Surgical Aortic Biological Prostheses : "Sutureless Valves".Al-Attar N. E-journal of Cardiology Practice, Volume 10, n°14.
Yusuf M. FRCS, Van Praet F. MD, Stockman B. MD, De Grieck I. MD, MD PhD FETCS*Department of Cardiovascular and Thoracic SurgeryOLV Clinic, Aalst, Belgium.* Corresponding author : Casselman F.Authors' discosures: None declared.
© 2017 European Society of Cardiology. All rights reserved